Stockreport

Abbott Laboratories (NYSE:ABT) Receives FDA Approval For Coronary IVL System Trial In US [Yahoo! Finance]

Abbott Laboratories  (ABT) 
Last abbott laboratories earnings: 4/16 07:30 am Check Earnings Report
US:NYSE Investor Relations: abbott.com/investors.html
PDF Lithotripsy (IVL) System, a significant development within the realm of coronary artery disease treatment. This announcement comes in conjunction with the company's rece [Read more]